-
AI innovation set to transform chest X-ray reporting
We advised Oxipit, an AI medical imaging application developer, on a major partnership deal. On 17 February 2025, Unilabs, a leading European diagnostic services provider, announced the selection of Oxipit’s AI solutions to be deployed for chest X-rays throughout Unilabs’ European network. With this collaboration, two great companies are paving the way to better and […]
-
Our Life Sciences and Healthcare experts analysed the compatibility of Ukrainian legislation with European Union e-health regulations
In the autumn of 2024, we undertook a legal challenge in the field of e-health. We conducted an extensive legal analysis to assess how Ukrainian legislation aligns with European Union law regarding e-health and health data. We conducted this study on behalf of the Estonian Centre for International Development in collaboration with the Ukrainian law […]
-
Silmäasema acquires 25-year-old Estonian chain of optical stores
We advised the Finnish company Silmäasema Optiikka Oy on acquiring Eagle Vision, an Estonian chain of optical stores. Eagle Vision has been operating for nearly 25 years and owns six stores across Estonia that will continue under the Eagle Vision brand. In 2023, Eagle Vision had a turnover of approximately EUR 2.8 million. Eagle Vision […]
-
Our medical and healthcare experts helped create Estonia’s long-term personalised medicine programme
The aim of the extensive project initiated by the Ministry of Social Affairs in spring 2023 and carried out by the University of Tartu was to draw up a “Long-term personalised medicine programme for 2024-2034”. As a legal expert, the University of Tartu engaged the regional head of our medical and health care team, counsel […]
-
Novel public-private partnership contributes to the implementation of cancer control plan
We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]